These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 27699270

  • 1. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 2. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 16; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 3. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH.
    Lancet Diabetes Endocrinol; 2019 Feb 16; 7(2):93-105. PubMed ID: 30558909
    [Abstract] [Full Text] [Related]

  • 4. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May 16; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 5. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 16; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 16; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F, Ali DS, Almonaei K, Al-Alwani H, Khan AA, Brandi ML.
    Osteoporos Int; 2024 Apr 16; 35(4):717-725. PubMed ID: 37993691
    [Abstract] [Full Text] [Related]

  • 10. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.
    J Clin Endocrinol Metab; 2016 Jan 16; 101(1):334-42. PubMed ID: 26529632
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
    Scott LJ.
    BioDrugs; 2016 Feb 16; 30(1):41-8. PubMed ID: 26832358
    [Abstract] [Full Text] [Related]

  • 14. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr 16; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Feb 16; 29(2):511-515. PubMed ID: 29046930
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA, Foster BL.
    Drug Des Devel Ther; 2018 Feb 16; 12():3147-3161. PubMed ID: 30288020
    [Abstract] [Full Text] [Related]

  • 20. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.
    Whyte MP, Fujita KP, Moseley S, Thompson DD, McAlister WH.
    J Bone Miner Res; 2018 May 16; 33(5):868-874. PubMed ID: 29297597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.